i. 57 papers (15-Q1, 13-Q2, 8- Q3, 13- Q4, 8-not defined)-
1. Maluta SPI, Schaffer MPI*, Pioli FCOPI, Dall’Oglio SCOPI, Pasetto SCOPI, Schaffer PMCOPI, Weber BCOPI, Giri MGPI. Regional hyperthermia combined with chemo – radiotherapy in primary or recurrent locally advanced unresectable pancreatic cancer : An open – label comparative cohort trial. Strahlentherapie und Onkologie 2011, 187:619-25. *Corresponding author (Q1).
2. Schaffer MPI, Hofstetter ACOPI, Ertl-Wagner BCOPI, Batash RCOPI, P?schl JCOPI, Schaffer PMPI. Treatment of Astrocytoma Grade III with Photofrin II as a radiosensitiser, a case report. Strahlenther Onkol 2013, 189:972–976 (Q1).
3. Schaffer MPI, Ertl-Wagner BCOPI, Schaffer PMCOPI, Kulka UCOPI, Jori GCOPI, D?hmke ECOPI, Hofstetter API. The application of Photofrin II as a sensitizing agent for ionizing radiation- a new approach in tumor therapy? Current Medicinal Chemistry, 12, 763-771, 2005. (Q1).
Funding: AXCAN PHARMA- Phosensitisers as Radiosensitisers